Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease

Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system analyses up to one million DNA letters at once to predict how mutations affect gene regulation.
AlphaGenome focuses on the non-coding genome, which controls when and where genes activate.
Researchers trained the model on large human and mouse genetics databases.
Scientists believe the tool could accelerate cancer research and rare disease diagnosis.
AlphaGenome may also support new gene therapies by helping design targeted DNA sequences.